Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Journal of Translational Medicine
Published in: Journal of Translational Medicine 1/2007

Open Access 01-12-2007 | Editorial

Comments on the nonpharmaceutical interventions in New York City and Chicago during the 1918 flu pandemic

Author: John M Barry

Published in: Journal of Translational Medicine | Issue 1/2007

Login to get access

Abstract

This commentary was originally published in CIDRAP News and it is here reported almost verbatim to allow divulgation through open access. The Editorial summarizes John Barry's concerns about the value of accurate historical reporting and its implications in public policy determination. This short abstract was written by the Editor-in-Chief of the Journal of Translational Medicine to introduce the Editorial.
Literature
1.
Barry JM: The great influenza: the epic store of the deadliest plague in history. 2004, New York, Viking, First
2.
3.
Markel H, Lipman HB, Navarro JA, Sloan A, Michalsen JR, Stern AM, Cetron MS: Nonpharmaceutical interventions implemented by US cities during the 1918-1919 influenza pandemic. JAMA. 2007, 298: 644-654. 10.1001/jama.298.6.644.CrossRefPubMed
4.
5.
Barry JM: Nonpharmaceutical interventions implemented during the 1918-1919 influenza pandemic. JAMA. 2007, 298: 2260-2261. 10.1001/jama.298.19.2260-b.CrossRefPubMed
6.
Markel H, Lipman HB, Navarro JA, Cetron MS: Nonpharmaceutical interventions implemented during the 1918-1919 influenza pandemic - Reply. JAMA. 2007, 298: 2261-10.1001/jama.298.19.2261-a.
7.
8.
Metadata
Title
Comments on the nonpharmaceutical interventions in New York City and Chicago during the 1918 flu pandemic
Author
John M Barry
Publication date
01-12-2007
Publisher
BioMed Central
Published in
Journal of Translational Medicine / Issue 1/2007
Electronic ISSN: 1479-5876
DOI
https://doi.org/10.1186/1479-5876-5-65

Other articles of this Issue 1/2007

Journal of Translational Medicine 1/2007 Go to the issue

Research

Therapeutic T cells induce tumor-directed chemotaxis of innate immune cells through tumor-specific secretion of chemokines and stimulation of B16BL6 melanoma to secrete chemokines

Research

Tumor-specific T cells signal tumor destruction via the lymphotoxin β receptor

Research

CD39 activity correlates with stage and inhibits platelet reactivity in chronic lymphocytic leukemia

Research

Association between long-term neuro-toxicities in testicular cancer survivors and polymorphisms in glutathione-s-transferase-P1 and -M1, a retrospective cross sectional study

Research

Immune-mediated changes in actinic keratosis following topical treatment with imiquimod 5% cream

Research

Safety and efficacy of Y-90 microsphere treatment in patients with primary and metastatic liver cancer: The tumor selectivity of the treatment as a function of tumor to liver flow ratio
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits